Previous studies have demonstrated the tumorigenic effects of NDST1 in primary glioblastoma and breast cancer, suggesting that it is a promising target for anticancer therapy (He et al., 2014; Xue et al., 2019). This evidence concerns the gene NDST1 and glioblastoma.